Watchlist Price Alert

Compass Group (CMPGY)

OTC: CMPGY · Real-Time Price · USD

34.21

0.61 (1.80%)

At close: Jun 23, 2025, 3:59 PM

1.80% (1D)

Bid	34.2
Market Cap	58.06B
Revenue (ttm)	47.47B
Net Income (ttm)	2B
EPS (ttm)	0.86
PE Ratio (ttm)	39.78
Forward PE	30.82
Analyst	n/a

Ask	34.3
Volume	36,177
Avg. Volume (20D)	257,051
Open	33.72
Previous Close	33.60
Day's Range	33.72 - 34.25
52-Week Range	27.39 - 36.70
Beta	0.64

About CMPGY

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CMPGY

Website n/a

Full Company Profile

News

1 day ago · barrons.com

Compass is Suing Zillow Over New Listing Rules. Why Buyers and Sellers Should Pay Attention.

At the heart of the rift is a disagreement over industry norms that could change how buyers shop and how sellers list homes.

1 day ago · businesswire.com

Compass Minerals Appoints Chief Accounting Officer

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today announced the appointment of Ashley Ward to chief accounting officer. She mos...

1 day ago · pymnts.com

Real Estate Broker Compass Accuses Zillow of ‘Anticompetitive' Behavior

Real estate brokerage Compass has reportedly sued Zillow for its ban on private home listings. [contact-form-7] The suit, filed Monday (June 23) in federal court in Manhattan, accuses Zillow of employ...

1 day ago · proactiveinvestors.com

atai Life Sciences backed by positive sector readthrough from Compass Phase 3 data, analysts say

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) remains a ‘Buy' for analysts at Jefferies, who continue to see significant upside ahead for the company following the release of new data from Compass Pathway...

1 day ago · theguardian.com

Compass sues Zillow over ‘monopoly tactics' in private home listings

Real estate company alleges that the ‘Zillow ban' prevents rivals from competing against it

19 hours ago · reuters.com

Compass sues Zillow for allegedly stifling competition for home listings

Compass , the largest U.S. residential real estate brokerage by sales volume, sued Zillow on Monday, accusing the nation's largest online real estate portal of violating federal antitrust law by consp...

19 hours ago · proactiveinvestors.com

Compass Pathways' late-stage psilocybin trial targeting treatment-resistant depression meets primary endpoint

Compass Pathways (NASDAQ:CMPS) has reported positive results from its Phase 3 trial of its synthetic formulation of psilocybin, COMP360, in patients with treatment-resistant depression (TRD), with the...

21 hours ago · geekwire.com

Compass sues Zillow, escalating private listings fight

This story originally appeared on Real Estate News.

1 day ago · invezz.com

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Shares of Compass Pathways Plc plunged as much as 37% during pre-market trading on Monday after the company's experimental psilocybin treatment for a form of hard-to-treat depression produced results ...

1 day ago · reuters.com

Compass Pathways' depression drug succeeds late-stage trial

Compass Pathways said on Monday its experimental psilocybin-based therapy helped significantly reduce symptoms of difficult-to-treat depression in a late-stage study.

Load More News